Key Metrics
Journal Specifications
- PublisherAEPRESS SRO
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1954
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Neoplasma been publishing? 
The Neoplasma has been publishing since 1954 till date.
How frequently is the Neoplasma published? 
Neoplasma is published Bi-monthly.
Who is the publisher of Neoplasma? 
The publisher of Neoplasma is AEPRESS SRO.
How can I view the journal metrics of Neoplasma on editage? 
For the Neoplasma metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Neoplasma? 
The eISSN number is 1338-4317 and pISSN number is 0028-2685 for Neoplasma.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Cancer, Western blot, Overall survival, Lung cancer, Assay, Pleural effusion, Dexamethasone, Cisplatin, Hepatocellular carcinoma, Cytidine deaminase, Gene expression, Principal component analysis, Cell migration, Breast cancer, Colorectal cancer, Bioinformatics, Transcription factor, Osteosarcoma, Peripheral blood, Pheochromocytoma.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.